Let’s dig into the relative performance of Merck (NYSE:MRK) and its peers as we unravel the now-completed Q4 branded ...

Idvynso combines doravirine and islatravir in a once-daily tablet cleared for adults already suppressing HIV on stable ...

As pharma giants slash headcounts and routinely strike billion-dol | Amid industry layoffs and M&A headlines, Big Pharma's ...

After prevailing in two kidney cancer trials in the refractory and early-stage settings, Merck & Co.’s blockbuster prospect ...

A tougher market puts two healthcare dividend giants in focus, as investors weigh income, stability, valuation, and long-term ...

By Michael Erman NEW YORK, April 22 (Reuters) - Drugmaker Merck & Co said on Wednesday it will partner with Google Cloud to ...

Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for ...

An Illinois jury in Cook County Circuit Court handed Merck a defense verdict on April 17 after fewer than two hours of ...

Merck KGaA plans to replace most of its animal testing protocols with advanced preclinical models over the next decade, aligning with a global regulatory push toward human-centric approaches. Experts ...

Merck is bracing for lower first-quarter Gardasil sales due to weak demand in China and Japan, compounded by a temporary shipment halt to its Chinese partner Zhifei. While other legacy vaccines also ...

April 21 (Reuters) - Merck and Eisai's experimental combination treatments failed to significantly improve survival or reduce ...

As multiple other organizations are joining Google cloud amid Artificial Intelligence AI technology push. Drugmaker Merck & ...